【市場調査レポート】固相オリゴヌクレオチド合成装置のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Solid-phase Oligonucleotide Synthesis Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。固相オリゴヌクレオチド合成装置のグローバル市場インサイト・予測（～2028年） / Global Solid-phase Oligonucleotide Synthesis Market Insights, Forecast to 2028 / QY2207E09285資料のイメージです。

• レポートコード：QY2207E09285
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の固相オリゴヌクレオチド合成装置の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に固相オリゴヌクレオチド合成装置の世界市場のxxx％を占める「プライマー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「民間用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の固相オリゴヌクレオチド合成装置の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの固相オリゴヌクレオチド合成装置市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの固相オリゴヌクレオチド合成装置市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

固相オリゴヌクレオチド合成装置のグローバル主要メーカーには、Genescript、GeneArt (Thermofischer)、Renesas Electronics Corporation、DNA 2.0 (ATUM)、OriGene、BBI、Genewiz、Eurofins Genomics、Gene Oracle、SBS Genetech、Bio Basicなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

固相オリゴヌクレオチド合成装置市場は、種類と用途によって区分されます。世界の固相オリゴヌクレオチド合成装置市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
プライマー、プローブ、中量合成オリゴ、大量合成オリゴ、リンカー＆添加剤

【用途別セグメント】
民間用、学術研究用

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 固相オリゴヌクレオチド合成装置製品概要
- 種類別市場（プライマー、プローブ、中量合成オリゴ、大量合成オリゴ、リンカー＆添加剤）
- 用途別市場（民間用、学術研究用）
- 調査の目的
・エグゼクティブサマリー
- 世界の固相オリゴヌクレオチド合成装置販売量予測2017-2028
- 世界の固相オリゴヌクレオチド合成装置売上予測2017-2028
- 固相オリゴヌクレオチド合成装置の地域別販売量
- 固相オリゴヌクレオチド合成装置の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別固相オリゴヌクレオチド合成装置販売量
- 主要メーカー別固相オリゴヌクレオチド合成装置売上
- 主要メーカー別固相オリゴヌクレオチド合成装置価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（プライマー、プローブ、中量合成オリゴ、大量合成オリゴ、リンカー＆添加剤）
- 固相オリゴヌクレオチド合成装置の種類別販売量
- 固相オリゴヌクレオチド合成装置の種類別売上
- 固相オリゴヌクレオチド合成装置の種類別価格
・用途別市場規模（民間用、学術研究用）
- 固相オリゴヌクレオチド合成装置の用途別販売量
- 固相オリゴヌクレオチド合成装置の用途別売上
- 固相オリゴヌクレオチド合成装置の用途別価格
・北米市場
- 北米の固相オリゴヌクレオチド合成装置市場規模（種類別、用途別）
- 主要国別の固相オリゴヌクレオチド合成装置市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの固相オリゴヌクレオチド合成装置市場規模（種類別、用途別）
- 主要国別の固相オリゴヌクレオチド合成装置市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の固相オリゴヌクレオチド合成装置市場規模（種類別、用途別）
- 主要国別の固相オリゴヌクレオチド合成装置市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の固相オリゴヌクレオチド合成装置市場規模（種類別、用途別）
- 主要国別の固相オリゴヌクレオチド合成装置市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの固相オリゴヌクレオチド合成装置市場規模（種類別、用途別）
- 主要国別の固相オリゴヌクレオチド合成装置市場規模（トルコ、サウジアラビア）
・企業情報
Genescript、GeneArt (Thermofischer)、Renesas Electronics Corporation、DNA 2.0 (ATUM)、OriGene、BBI、Genewiz、Eurofins Genomics、Gene Oracle、SBS Genetech、Bio Basic
・産業チェーン及び販売チャネル分析
- 固相オリゴヌクレオチド合成装置の産業チェーン分析
- 固相オリゴヌクレオチド合成装置の原材料
- 固相オリゴヌクレオチド合成装置の生産プロセス
- 固相オリゴヌクレオチド合成装置の販売及びマーケティング
- 固相オリゴヌクレオチド合成装置の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 固相オリゴヌクレオチド合成装置の産業動向
- 固相オリゴヌクレオチド合成装置のマーケットドライバー
- 固相オリゴヌクレオチド合成装置の課題
- 固相オリゴヌクレオチド合成装置の阻害要因
・主な調査結果

Market Analysis and Insights: Global Solid-phase Oligonucleotide Synthesis Market
The global Solid-phase Oligonucleotide Synthesis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Primers accounting for % of the Solid-phase Oligonucleotide Synthesis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Commercial segment is altered to an % CAGR throughout this forecast period.
China Solid-phase Oligonucleotide Synthesis market size is valued at US$ million in 2021, while the North America and Europe Solid-phase Oligonucleotide Synthesis are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Solid-phase Oligonucleotide Synthesis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Solid-phase Oligonucleotide Synthesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Solid-phase Oligonucleotide Synthesis market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Solid-phase Oligonucleotide Synthesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Solid-phase Oligonucleotide Synthesis market.
Global Solid-phase Oligonucleotide Synthesis Scope and Market Size
Solid-phase Oligonucleotide Synthesis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Solid-phase Oligonucleotide Synthesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
Segment by Application
Commercial
Academic Research
By Company
Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2017-2028)
2.2 Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Solid-phase Oligonucleotide Synthesis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2017-2022)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2017-2022)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2017-2022)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2021
3.5 Solid-phase Oligonucleotide Synthesis Key Players Head office and Area Served
3.6 Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service
3.7 Date of Enter into Solid-phase Oligonucleotide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2017-2022)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2017-2022)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type
6.2.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
6.2.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
6.2.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Application
6.3.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
6.3.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
6.3.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
6.4.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
6.4.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type
7.2.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
7.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
7.2.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application
7.3.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
7.3.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
7.3.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
7.4.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
7.4.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type
8.2.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application
8.3.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region
8.4.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type
9.2.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
9.2.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
9.2.3 Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application
9.3.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
9.3.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
9.3.3 Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country
9.4.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
9.4.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type
10.2.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application
10.3.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country
10.4.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.1.5 Genescript Recent Developments
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.2.5 GeneArt (Thermofischer) Recent Developments
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.3.5 Renesas Electronics Corporation Recent Developments
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.4.5 DNA 2.0 (ATUM) Recent Developments
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.5.5 OriGene Recent Developments
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.6.5 BBI Recent Developments
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.7.5 Genewiz Recent Developments
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.8.5 Eurofins Genomics Recent Developments
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.9.5 Gene Oracle Recent Developments
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.10.5 SBS Genetech Recent Developments
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.11.5 Bio Basic Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Primers
Table 3. Key Players of Probes
Table 4. Key Players of Intermediate-scale Synthesis Oligos
Table 5. Key Players of Large-scale Synthesis Oligos
Table 6. Key Players of Linkers and Adaptors
Table 7. Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2017-2022)
Table 11. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Solid-phase Oligonucleotide Synthesis Market Share by Region (2023-2028)
Table 13. Solid-phase Oligonucleotide Synthesis Market Trends
Table 14. Solid-phase Oligonucleotide Synthesis Market Drivers
Table 15. Solid-phase Oligonucleotide Synthesis Market Challenges
Table 16. Solid-phase Oligonucleotide Synthesis Market Restraints
Table 17. Global Solid-phase Oligonucleotide Synthesis Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players (2017-2022)
Table 19. Global Top Solid-phase Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2021)
Table 20. Ranking of Global Top Solid-phase Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service
Table 24. Date of Enter into Solid-phase Oligonucleotide Synthesis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2017-2022)
Table 28. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type (2023-2028)
Table 30. Global Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2017-2022)
Table 32. Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application (2023-2028)
Table 34. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028) & (US$ Million)
Table 64. Genescript Company Details
Table 65. Genescript Business Overview
Table 66. Genescript Solid-phase Oligonucleotide Synthesis Product
Table 67. Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 68. Genescript Recent Developments
Table 69. GeneArt (Thermofischer) Company Details
Table 70. GeneArt (Thermofischer) Business Overview
Table 71. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product
Table 72. GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 73. GeneArt (Thermofischer) Recent Developments
Table 74. Renesas Electronics Corporation Company Details
Table 75. Renesas Electronics Corporation Business Overview
Table 76. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product
Table 77. Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 78. Renesas Electronics Corporation Recent Developments
Table 79. DNA 2.0 (ATUM) Company Details
Table 80. DNA 2.0 (ATUM) Business Overview
Table 81. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product
Table 82. DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 83. DNA 2.0 (ATUM) Recent Developments
Table 84. OriGene Company Details
Table 85. OriGene Business Overview
Table 86. OriGene Solid-phase Oligonucleotide Synthesis Product
Table 87. OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 88. OriGene Recent Developments
Table 89. BBI Company Details
Table 90. BBI Business Overview
Table 91. BBI Solid-phase Oligonucleotide Synthesis Product
Table 92. BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 93. BBI Recent Developments
Table 94. Genewiz Company Details
Table 95. Genewiz Business Overview
Table 96. Genewiz Solid-phase Oligonucleotide Synthesis Product
Table 97. Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 98. Genewiz Recent Developments
Table 99. Eurofins Genomics Company Details
Table 100. Eurofins Genomics Business Overview
Table 101. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product
Table 102. Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 103. Eurofins Genomics Recent Developments
Table 104. Gene Oracle Company Details
Table 105. Gene Oracle Business Overview
Table 106. Gene Oracle Solid-phase Oligonucleotide Synthesis Product
Table 107. Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 108. Gene Oracle Recent Developments
Table 109. SBS Genetech Company Details
Table 110. SBS Genetech Business Overview
Table 111. SBS Genetech Solid-phase Oligonucleotide Synthesis Product
Table 112. SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 113. SBS Genetech Recent Developments
Table 114. Bio Basic Company Details
Table 115. Bio Basic Business Overview
Table 116. Bio Basic Solid-phase Oligonucleotide Synthesis Product
Table 117. Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022) & (US$ Million)
Table 118. Bio Basic Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid-phase Oligonucleotide Synthesis Market Share by Type: 2021 VS 2028
Figure 2. Primers Features
Figure 3. Probes Features
Figure 4. Intermediate-scale Synthesis Oligos Features
Figure 5. Large-scale Synthesis Oligos Features
Figure 6. Linkers and Adaptors Features
Figure 7. Global Solid-phase Oligonucleotide Synthesis Market Share by Application: 2021 VS 2028
Figure 8. Commercial Case Studies
Figure 9. Academic Research Case Studies
Figure 10. Solid-phase Oligonucleotide Synthesis Report Years Considered
Figure 11. Global Solid-phase Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Solid-phase Oligonucleotide Synthesis Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Solid-phase Oligonucleotide Synthesis Market Share by Region: 2021 VS 2028
Figure 14. Global Solid-phase Oligonucleotide Synthesis Market Share by Players in 2021
Figure 15. Global Top Solid-phase Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid-phase Oligonucleotide Synthesis as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Solid-phase Oligonucleotide Synthesis Revenue in 2021
Figure 17. North America Solid-phase Oligonucleotide Synthesis Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2028)
Figure 19. North America Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2028)
Figure 20. North America Solid-phase Oligonucleotide Synthesis Market Size Share by Country (2017-2028)
Figure 21. United States Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Solid-phase Oligonucleotide Synthesis Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2028)
Figure 25. Europe Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2028)
Figure 26. Europe Solid-phase Oligonucleotide Synthesis Market Size Share by Country (2017-2028)
Figure 27. Germany Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Solid-phase Oligonucleotide Synthesis Market Size Share by Region (2017-2028)
Figure 37. China Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Solid-phase Oligonucleotide Synthesis Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Solid-phase Oligonucleotide Synthesis Market Size Share by Country (2017-2028)
Figure 47. Mexico Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size Share by Country (2017-2028)
Figure 53. Turkey Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Solid-phase Oligonucleotide Synthesis Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Genescript Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 57. GeneArt (Thermofischer) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 58. Renesas Electronics Corporation Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 59. DNA 2.0 (ATUM) Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 60. OriGene Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 61. BBI Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 62. Genewiz Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 63. Eurofins Genomics Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 64. Gene Oracle Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 65. SBS Genetech Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 66. Bio Basic Revenue Growth Rate in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global Antisense Oligonucleotide (ASO) Therapeutics Market Insights, Forecast to 2028
QY2207E09222 2022年7月 107Pages
新型コロナウイルス感染症のパンデミックにより、世界のアンチセンスオリゴヌクレオチド（ASO）治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2...

世界の固相抽出（SPE）装置市場予測（～2028年）：SPEカートリッジ、SPEディスク、ウェルプレート

Global Solid Phase Extraction (SPE) Equipment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E7198 2022年5月 107Pages
固相抽出（SPE）装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供しま...

航空機用電気ソリッドステートパワーコントローラーのグローバル市場インサイト・予測（～2028年）

Global Aircraft Electrical Solid-State Power Controller Market Insights, Forecast to 2028
QY2207E04317 2022年7月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界の航空機用電気ソリッドステートパワーコントローラーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、...

第I～IV相臨床開発サービスのグローバル市場インサイト・予測（～2028年）

Global Phase I - IV Clinical Development Services Market Insights, Forecast to 2028
QY2207E10464 2022年7月 126Pages
新型コロナウイルス感染症のパンデミックにより、世界の第I～IV相臨床開発サービスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に第I～I...

合成ホットセルのグローバル市場インサイト・予測（～2028年）

Global Synthesis Hot Cell Market Insights, Forecast to 2028
QY2207E08577 2022年7月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の合成ホットセルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に合成ホットセルの世界市...

アンチセンスオリゴヌクレオチド（ASO）治療薬のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Antisense Oligonucleotide (ASO) Therapeutics Market The global Antisense Oligonucleotide (ASO) Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by …
合成ホットセルのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Synthesis Hot Cell Market Due to the COVID-19 pandemic, the global Synthesis Hot Cell market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully…
世界の固相抽出（SPE）装置市場予測（～2028年）：SPEカートリッジ、SPEディスク、ウェルプレート The Solid Phase Extraction (SPE) Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
世界の超大規模（ULSI）IC市場予測（～2028年）：薄膜IC、厚膜IC The Ultra Large Scale (ULSI) ICs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
血液銀行規模のグローバル市場インサイト・予測（～2028年） Blood bank scales are microcontroller based blood bank weighing scales designed for weighing blood and blood components. Market Analysis and Insights: Global Blood Bank Scale Market Due to the COVID-19 pandemic, the global Blood Bank Scale market size is estimated to be worth US$ million in 2022 and…